These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3421459)

  • 1. Multiple anaesthetics for a malignant hyperthermia susceptible patient.
    Emmanuel ER
    Anaesthesia; 1988 Aug; 43(8):666-70. PubMed ID: 3421459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anesthesia in malignant hyperthermia susceptible patients.
    Mauritz W; Hackl W; Winkler M; Sporn P; Steinbereithner K
    Acta Anaesthesiol Belg; 1990; 41(2):87-94. PubMed ID: 1973553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anesthesia for patients with a history of malignant hyperthermia.
    Wappler F
    Curr Opin Anaesthesiol; 2010 Jun; 23(3):417-22. PubMed ID: 20173632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of a patient with malignant hyperthermia susceptibility during anesthesia and daily living].
    Jacquot C; Stieglitz P
    Ann Fr Anesth Reanim; 1989; 8(5):417-26. PubMed ID: 2697156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple anaesthetics for a malignant hyperthermia susceptible patient.
    Lloyd EL
    Anaesthesia; 1989 Jan; 44(1):76-7. PubMed ID: 2929919
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anesthesiologic management of susceptible children at risk for malignant hyperthermia].
    Ferrari F; D'Alessandro S; Pietrandrea G; Villani A
    Minerva Anestesiol; 1997 Oct; 63(10):311-4. PubMed ID: 9567608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus guidelines on perioperative management of malignant hyperthermia suspected or susceptible patients from the European Malignant Hyperthermia Group.
    Rüffert H; Bastian B; Bendixen D; Girard T; Heiderich S; Hellblom A; Hopkins PM; Johannsen S; Snoeck MM; Urwyler A; Glahn KPE;
    Br J Anaesth; 2021 Jan; 126(1):120-130. PubMed ID: 33131754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of exposure of malignant hyperthermia non-susceptible patients and their relatives to anaesthetic triggering agents.
    Pollock N; Langton EE; Stowell KM; Bulger TF
    Anaesth Intensive Care; 2011 Sep; 39(5):887-94. PubMed ID: 21970134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant hyperthermia susceptibility: anaesthetic implications and risk stratification.
    Ben Abraham R; Cahana A; Krivosic-Horber RM; Perel A
    QJM; 1997 Jan; 90(1):13-8. PubMed ID: 9093584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anesthesia for elective surgery in patients susceptible to malignant hyperthermia.
    Relton JE
    Int Anesthesiol Clin; 1979; 17(4):141-51. PubMed ID: 521179
    [No Abstract]   [Full Text] [Related]  

  • 11. Malignant hyperthermia and the otolaryngologist.
    Chang CY; Scher RL
    Ear Nose Throat J; 2003 Jun; 82(6):433-6. PubMed ID: 12861868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiopulmonary bypass in malignant hyperthermia susceptible patients: a systematic review of published cases.
    Metterlein T; Zink W; Kranke E; Haneya A; Graf B; Kranke P
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1488-95. PubMed ID: 21376345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative determination of susceptibility to malignant hyperthermia.
    Carson JM; Van Sickels JE
    J Oral Maxillofac Surg; 1982 Jul; 40(7):432-5. PubMed ID: 6953194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of neuroleptoanesthesia for carrying out a Harrington intervention in a patient probably susceptible to malignant hyperthermia].
    Lauri A; Corbari M; Galli C; Marri M
    Minerva Anestesiol; 1989 Sep; 55(9):331-5. PubMed ID: 2633080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of anaesthetics received by patients before susceptibility to malignant hyperpyrexia was recognized.
    Halsall PJ; Cain PA; Ellis FR
    Br J Anaesth; 1979 Oct; 51(10):949-54. PubMed ID: 518796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidural anesthetic management using ropivacaine in a parturient with multi-minicore disease and susceptibility to malignant hyperthermia.
    Saito O; Yamamoto T; Mizuno Y
    J Anesth; 2007; 21(1):113. PubMed ID: 17285432
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurosurgery in the malignant hyperthermia-susceptible patient.
    Wackym PA; Dubrow TJ; Abdul-Rasool IH; Peacock WJ
    Neurosurgery; 1988 Jun; 22(6 Pt 1):1032-6. PubMed ID: 3419564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the use of local anesthetics in the dental treatment of patients who are susceptible to malignant hyperthermia.
    D'Ambrosio J; Adragna MG
    Spec Care Dentist; 1988; 8(2):61-3. PubMed ID: 2978768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anaesthesia in a patient susceptible to malignant hyperthermia (author's transl)].
    Schuh FT; Maier C
    Anaesthesist; 1982 May; 31(5):245-7. PubMed ID: 7103032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant hyperthermia susceptibility in patients with osteogenesis imperfecta.
    Peluso A; Cerullo M
    Paediatr Anaesth; 1995; 5(6):398-9. PubMed ID: 8597980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.